COMMUNIQUÉS West-GlobeNewswire

Er-Kim Announces Positive Reimbursement Decision in the Czech Republic for Vafseo® (vadadustat) to Treat Symptomatic Anaemia in Adult CKD Dialysis Patients
15/09/2026
State Institute for Drug Control (SÚKL) has officially evaluated and approved the drug’s price and coverage under the public health insurance system WARSAW, Poland, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Er-Kim , an [...]
New Data Reveal Rapid, Sustained Quality-of-Life Improvements for Eczema and Psoriasis Patients Using Zest Health's Virtual Dermatology Platform
15/09/2026
Findings published in Dermatology Practical & Conceptual show a 65.5% reduction in disease-related quality-of-life impact and a more than 4x drop in severe cases by patients' final visit WASHINGTON, Sept. 15, 2026 ( [...]
Sonus Microsystems and Medtronic Partner to Advance AI-Powered Maternal Health Monitoring
15/09/2026
Partnership will pair Medtronic vital-sign monitoring with Sonus’s ultrasound AI platform in field studies, funded by the Gates Foundation VANCOUVER, British Columbia and LAFAYETTE, Colo., Sept. 15, 2026 (GLOBE NEWSWIRE [...]
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
15/09/2026
NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set for June 29, 2027 [...]
Kestrel Therapeutics Receives FDA Fast Track Designation for KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in the treatment of KRAS-Mutant Advanced Solid Tumors
15/09/2026
WATERTOWN, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical-stage biotechnology company developing next-generation small-molecule inhibitors targeting mutant [...]
Addgene Launches Transfection-Ready DNA Service to Accelerate Academic and Industry Research
15/09/2026
Sourced from Addgene’s trusted repository, thousands of plasmids are now available to researchers as high-purity, NGS sequence-verified DNA WATERTOWN, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Addgene , a purpose-driven [...]
NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
15/09/2026
SANTA ANA, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
15/09/2026
CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today [...]
Dimenso Raises $650,000 to Bring Physical AI and Smart Glasses to Life Sciences Laboratories
15/09/2026
Boston-based company backed by Draper B1 and Next Tier Ventures is building AI infrastructure to capture, structure, and understand scientific work as it happens Dimenso has raised $650,000 from Draper B1 and Next Tier [...]
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
15/09/2026
Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 million Company remains eligible for up to approximately $10 million in additional proceeds [...]
PolyPid Announces Participation in Upcoming Fall Investor Conferences
15/09/2026
PETACH TIKVA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment [...]
Sienna Announces September Dividend
15/09/2026
MARKHAM, Ontario, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing
15/09/2026
ERNA-201 demonstrated encouraging disease-modifying activity in the industry-standard collagen-induced arthritis model, providing meaningful proof-of-concept for Ernexa's engineered synthetic iMSC platform beyond [...]
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
15/09/2026
LAS VEGAS, NV, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related [...]
Tria Federal Achieves CMMC Level 2 Certification, Affirming Its Ability to Protect Sensitive Federal Data
15/09/2026
Rigorous, independent audit confirms Tria's security controls meet the Department of War’s standard ARLINGTON, Va., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Tria Federal today announced that it has achieved Cybersecurity [...]
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
15/09/2026
Chaired by Mo Qatanani, PhD, Clinical & Scientific Advisory Board brings deep expertise in obesity, cardiometabolic disease and drug development Board will guide MitoRx's development strategy for lead asset MTRX31 [...]
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
15/09/2026
-- Leading multi-site OB/GYN health practice to implement FemVue ® for fertility diagnostic evaluation and FemaSeed for first-line treatment across all four locations -- ATLANTA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- [...]
New Imprivata Research Finds 72% of Healthcare Organizations Have AI Tools or Agents Deployed Without Formal IT Approval
15/09/2026
Survey of U.S. healthcare leaders reveals that AI adoption is accelerating, but unapproved deployments and fragmented identity security strategies create governance challenges WALTHAM, Mass., Sept. 15, 2026 (GLOBE [...]
KORTUC Achieves Target Enrollment in Registrational Breast Cancer Trial as Three Global Clinical Programs Advance
15/09/2026
The 184-patient milestone moves KORTUC's lead program toward readout, alongside a cervical cancer study with UC San Diego and newly authorized K-BOOST rectal cancer trial in France PALO ALTO, Calif., Sept. 15, 2026 ( [...]

Pages